Brief: Genocea Announces Material Transfer And License Option Agreement With Shionogi For Proprietary Gen-003 Hsv-2 Antigens

Genocea Biosciences

19/05/2020 12:53

May 19 (Reuters) - Genocea Biosciences Inc  GNCA.O :
    * GENOCEA ANNOUNCES MATERIAL TRANSFER AND LICENSE OPTION
AGREEMENT
WITH SHIONOGI FOR PROPRIETARY GEN-003 HSV-2 ANTIGENS
    * GENOCEA BIOSCIENCES INC - SHIONOGI WILL PAY $2 MILLION FOR
EXCLUSIVE OPTION TO EVALUATE HSV-2 ANTIGENS
    * GENOCEA BIOSCIENCES INC - FINAL TERMS OF LICENSE AGREEMENT
WILL
BE BASED ON RESULTS OF MTA EVALUATION AND OVERALL DILIGENCE
    * GENOCEA BIOSCIENCES - IF LICENSED, SHIONOGI WILL ASSUME
RESPONSIBILITY FOR GLOBAL DEVELOPMENT AND COMMERCIALIZATION OF
HSV-2 VACCINE PRODUCT

Source text for Eikon:  ID:nGNX5px87C 
Further company coverage:  GNCA.O 

 (Reuters.Briefs@thomsonreuters.com)